Expanding Chemical Products Capacity Through New Plants
First written in FY2016. 19 of 34 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-07-31.
126 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The Group made capital investments totaling ¥8,081 million, primarily in the Abrasives Business and Chemical Products Business, to improve quality and expand capacity, rationalize and reduce labor requirements, and conduct R&D for new products.」
The company invested ¥4,432 million in the Chemical Products Business and proceeded with new installations and replacements to expand production capacity. It also disclosed a new ¥808 million capital investment plan at the Yanai Plant, scheduled to begin in April 2026. - 2026-05-15AchievedRevision of earnings forecasts
「In the chemical products business, we expect performance to remain generally steady, supported by expansion in the electronic materials market and the stable operation of the new plant, which began operating in April 2026.」
The new plant, intended to expand capacity, began operating in April 2026. - FY2026-H1AdvancedAnnual report
「The Yanai and Takefu plants also maintained generally high utilization rates. As a result, net sales increased by ¥391 million, or 5.7%, year on year to ¥7,212 million, while operating income increased by ¥131 million, or 22.1%, to ¥726 million.」
In the Chemical Products Business, orders remained firm against a backdrop of growth in the electronic materials market and signs of recovery in agrochemical market conditions, while both plants maintained high utilization. Net sales and operating income also exceeded the previous year’s levels. - FY2025AdvancedAnnual report
「Yanai Chemical Industry Co., Ltd. — Head Office Plant (Yanai, Yamaguchi) — Chemical Products Business — Organic synthetic products — Production equipment — 6,200 — 1,241 — Same as above — October 2023 — April 2026 — Production capacity to increase by 14%」
The company disclosed a plan for new production equipment at the Yanai Plant, with a total investment of ¥6,200 million, ¥1,241 million paid to date, completion scheduled for April 2026, and production capacity expected to increase by 14%. - FY2025-H1AdvancedAnnual report
「Although the impact of the sluggish Chinese economy since last year continued, demand began to recover as the electronic materials market, including semiconductors, expanded gradually and inventory adjustments ran their course. In addition, initiatives for new products proved successful, improving plant utilization. As a result, net sales increased by ¥434 million year on year to ¥6,820 million, while operating income increased by ¥253 million to ¥595 million.」
In the Chemical Products Business, initiatives for new products improved plant utilization, and net sales and operating income exceeded the previous year’s levels as demand recovered. - FY2024-Q3RestatedAnnual report
「Contract manufacturing of functional materials, pharmaceutical intermediates and agrochemical intermediates faced a challenging operating environment as demand remained weak across the chemical industry, particularly due to deteriorating market conditions for electronic materials centered on semiconductors. Orders for functional materials were weak except in some areas, while strong orders for agrochemical intermediates were maintained. The company proceeded with price pass-through for the portion of higher manufacturing costs attributable to surging raw material and energy prices.」
In the Chemical Products Business, the company continues to maintain orders for agrochemical intermediates and implement price pass-through amid weak demand and deteriorating electronic materials market conditions. - FY2024-Q2RestatedAnnual report
「Contract manufacturing of some functional materials, pharmaceutical intermediates and agrochemical intermediates remained firm as the trend toward reshoring chemical products production to Japan continued amid the emergence of overseas production risks. Meanwhile, the chemical industry as a whole faced a challenging operating environment due to declining global demand and deteriorating market conditions for electronic materials, particularly semiconductors, resulting in an overall decline in orders. The company implemented price pass-through for the portion of higher product costs attributable to surging raw material and energy prices.」
The company maintained the reshoring of production to Japan driven by overseas production risks and the firmness of some contract manufacturing operations, while reporting an overall decline in orders due to weaker demand and deteriorating electronic materials market conditions, as well as the implementation of price pass-through. - FY2023AdvancedAnnual report
「Yanai Chemical Industry Co., Ltd. — Head Office Plant (Yanai, Yamaguchi) — Chemical Products Business — Organic synthetic products — Production equipment — 652 — — — Same as above — April 2023 — March 2024 — Almost none, for quality improvement and rationalization」
The company disclosed a plan to install ¥652 million of production equipment at the Yanai Plant for the Chemical Products Business, advancing quality improvement and rationalization. - FY2023-Q3RestatedAnnual report
「The Chemical Products Business continues to operate both the Yanai and Takefu plants at full capacity」
The company continues full-capacity operations at the Yanai and Takefu plants and stable production of chemical products. - FY2023-Q2RestatedAnnual report
「Contract manufacturing of functional materials, pharmaceutical intermediates and agrochemical intermediates continued stable production, mainly for agrochemical and functional materials applications, as the recovery in domestic demand, the impact of environmental regulations in China and the emergence of overseas production risks due to the spread of COVID-19 continued to drive the reshoring of chemical products production to Japan. Although sales remained solid, earnings were pressured by higher raw material, fuel and utility costs.」
The company continued stable production for agrochemical and functional materials applications and maintained operations at both the Yanai and Takefu plants, supported by the reshoring of production to Japan, while higher raw material, fuel and utility costs pressured earnings. - FY2023-Q1RestatedAnnual report
「Contract manufacturing of functional materials, pharmaceutical intermediates and agrochemical intermediates continued stable production, mainly for agrochemical and functional materials applications, as the recovery in domestic demand, changes in overseas conditions and the emergence of overseas production risks due to the spread of COVID-19 continued to drive the reshoring of chemical products production to Japan.」
The company continues stable production of chemical products, supported by the recovery in domestic demand and the reshoring of production to Japan, while noting that higher raw material, fuel and utility costs pressured earnings. - FY2022AdvancedAnnual report
「Yanai Chemical Industry Co., Ltd. — Head Office Plant (Yanai, Yamaguchi) — Chemical Products Business — Organic synthetic products — Production equipment — 1,050 — — — Same as above — April 2022 — March 2023 — Almost none, for quality improvement and rationalization」
The company newly disclosed a plan to invest ¥1,050 million in production equipment at the Yanai Plant for the Chemical Products Business, with completion scheduled for March 2023. - FY2022-Q3RestatedAnnual report
「Contract manufacturing of functional chemicals, pharmaceutical intermediates and other products continued stable production, mainly for agrochemical and functional materials applications, as domestic demand recovered after the impact of COVID-19 subsided and the trend toward reshoring chemical products production to Japan continued due to supply chain reviews and the impact of environmental regulations in China. Although raw material costs and depreciation and amortization increased, the expanded production lines also contributed to higher earnings.」
The company continues to report stable production supported by the recovery in domestic demand and the reshoring of production to Japan, as well as higher earnings from the expanded production lines. - FY2022-Q2AdvancedAnnual report
「Although depreciation and amortization increased, higher production from the newly installed production line also contributed to results, resulting in higher earnings. As a result, net sales decreased by ¥714 million, or 11.4%, year on year to ¥5,579 million, while operating income increased by ¥113 million, or 18.2%, to ¥734 million.」
In the Chemical Products Business, higher production from the newly installed production line took effect, increasing operating income by 18.2% year on year despite higher depreciation and amortization. - FY2022-Q1AdvancedAnnual report
「Although depreciation and amortization increased, the impact of higher production at the new plant also contributed to results, resulting in higher earnings. As a result, net sales decreased by ¥96 million, or 3.4%, year on year to ¥2,735 million, while operating income increased by ¥118 million, or 49.7%, to ¥358 million.」
In the Chemical Products Business, higher production at the new plant contributed to results, bringing operating income to ¥358 million, up 49.7% year on year despite higher depreciation and amortization. - FY2021AdvancedAnnual report
「Both the Yanai and Takefu plants maintained high utilization rates, resulting in record-high net sales and operating income. As a result, net sales increased by ¥364 million, or 2.7%, year on year to ¥13,664 million, while operating income increased by ¥117 million, or 9.3%, to ¥1,383 million.」
The Chemical Products Business maintained high utilization rates at both plants, bringing net sales to ¥13,664 million and operating income to ¥1,383 million, both record highs. - FY2020AdvancedAnnual report
「Contract manufacturing of functional chemicals, pharmaceutical intermediates and other products remained firm across all fields, centered on agrochemical and functional materials applications, as the trend toward reshoring chemical products production to Japan continued amid the impact of environmental regulations in China and demand for high-quality chemical products. Although some raw material deliveries from China were delayed at the end of the period due to the impact of COVID-19, both the Yanai and Takefu plants operated at full capacity throughout the period, resulting in record-high net sales and operating income.」
The Yanai and Takefu plants maintained full capacity throughout the year, with net sales of the Chemical Products Business at ¥13,300 million and operating income at ¥1,265 million, both record highs. - FY2020-Q3AdvancedAnnual report
「Contract manufacturing of functional chemicals, pharmaceutical intermediates and other products remained firm across all fields, centered on products for agrochemicals and functional materials, as the trend toward reshoring chemical products production to Japan continued amid the impact of environmental regulations in China and demand for high-quality chemical products. Both the Yanai and Takefu plants operated at full capacity. As a result, net sales increased by ¥1,631 million, or 19.9%, year on year to ¥9,831 million, while operating income increased by ¥381 million, or 69.9%, to ¥927 million.」
The Yanai and Takefu plants continued to operate at full capacity and remained firm across all fields. Net sales of the Chemical Products Business were ¥9,831 million and operating income was ¥927 million. - FY2020-Q2AdvancedAnnual report
「Contract manufacturing of functional chemicals, pharmaceutical intermediates and other products remained firm across all fields, centered on products for electronic materials, as the trend toward reshoring chemical products production to Japan continued amid the impact of environmental regulations in China and demand for high-quality chemical products. Both the Yanai and Takefu plants operated at full capacity. As a result, net sales increased by ¥1,578 million, or 30.7%, year on year to ¥6,718 million, while operating income increased by ¥282 million, or 81.9%, to ¥626 million.」
The Yanai and Takefu plants continued to operate at full capacity and remained firm across all fields. Net sales were ¥6,718 million and operating income was ¥626 million. - FY2020-Q1RestatedAnnual report
「Contract manufacturing of functional chemicals, pharmaceutical intermediates and other products remained firm across all fields, including functional chemicals for electronic materials, agrochemical intermediates and pharmaceutical intermediates. Amid the impact of environmental regulations in China and a continuing trend toward the reshoring to Japan of production of chemical products requiring high quality, both the Yanai and Takefu plants operated at full capacity.」
The Yanai and Takefu plants continue to operate at full capacity, supported by new orders and the reshoring of production to Japan. - FY2019AdvancedAnnual report
「Contract manufacturing of functional chemicals, pharmaceutical intermediates and other products remained firm, driven by new orders centered on functional chemicals. In addition, amid a trend toward the reshoring of chemical products production to Japan due to the impact of environmental regulations in China, both the Yanai and Takefu plants operated at full capacity, resulting in record-high net sales and operating income.」
Both the Yanai and Takefu plants operated at full capacity, bringing net sales of the Chemical Products Business to ¥11,305 million and operating income to ¥919 million, both record highs. The company also presented a plan to increase production capacity at the Takefu Plant by 12%. - FY2019-Q3AdvancedAnnual report
「Contract manufacturing of functional chemicals, pharmaceutical intermediates and other products remained firm, driven by new orders centered on functional chemicals. In addition, amid a trend toward the reshoring of chemical products production to Japan due to the impact of environmental regulations in China, both the Yanai and Takefu plants operated at full capacity.」
New orders and the reshoring of chemical products production to Japan brought both the Yanai and Takefu plants to full capacity. - FY2019-Q2AdvancedAnnual report
「Contract manufacturing of functional chemicals, pharmaceutical intermediates and other products remained firm, driven by new orders centered on functional chemicals. In addition, amid a trend toward the reshoring of chemical products production to Japan due to the impact of environmental regulations in China, both the Yanai and Takefu plants operated at full capacity. As a result, net sales increased by ¥529 million year on year to ¥5,140 million, while operating income increased by ¥62 million to ¥344 million.」
New orders and the reshoring of production to Japan amid China’s environmental regulations brought both the Yanai and Takefu plants to full capacity, with net sales and operating income exceeding the previous year’s levels. - FY2019-Q1AdvancedAnnual report
「Contract manufacturing of functional materials, pharmaceutical intermediates and other products operated at nearly full capacity as a result of stronger new order activities, although shipments of some agrochemical active ingredients and pharmaceutical intermediates products were pushed back to the latter half of the period.」
Stronger new order activities advanced contract manufacturing of chemical products from below full capacity to nearly full capacity. - FY2018RestatedAnnual report
「The Chemical Products Business strengthened new order activities and continued stable production, mainly through contract manufacturing of functional materials, agrochemical active ingredients and pharmaceutical intermediates. However, the plants did not reach full capacity because of delays in deliveries of raw materials from overseas and declining orders from some customers.」
The company continues to strengthen new order activities and maintain stable production, but has not reached full capacity because of delays in raw material deliveries and declining orders from some customers. - FY2018-Q3RestatedAnnual report
「Although contract manufacturing of functional chemicals, pharmaceutical intermediates and other products strengthened new order activities, mainly for functional materials, and continued stable production, the plants did not reach full capacity because of delays in deliveries of raw materials from overseas and declining orders from some customers.」
The company continues to strengthen new order activities and maintain stable production, but has not reached full capacity because of delays in raw material deliveries and declining orders from some customers. - FY2018-Q2RestatedAnnual report
「Although contract manufacturing of functional chemicals, pharmaceutical intermediates and other products strengthened new order activities, mainly for functional materials, and continued stable production, the plants did not reach full capacity because of delays in deliveries of raw materials from overseas and declining orders from some customers.」
The company strengthened new order activities, mainly for functional materials, and continued stable production, but did not reach full capacity because of delays in raw material deliveries and declining orders from some customers. - FY2018-Q1RestatedAnnual report
「Although contract manufacturing of functional chemicals, pharmaceutical intermediates and other products continued stable production, mainly of agrochemical intermediates, orders from some functional materials customers declined, preventing the plants from operating at full capacity.」
Contract manufacturing continued stable production, mainly of agrochemical intermediates, but the plants did not reach full capacity because orders from some customers declined. - FY2017-Q3RestatedAnnual report
「The contract manufacturing of functional chemicals, pharmaceutical intermediates and other products continued stable production, mainly of functional materials and agrochemical intermediates, following the increase in production capacity from the start-up of the new plant.」
The company continues to report increased production capacity and stable production following the start-up of the new plant. - FY2017-Q2RestatedAnnual report
「The contract manufacturing of functional chemicals, pharmaceutical intermediates and other products continued stable production, mainly of functional materials and agrochemical intermediates, following the increase in production capacity from the start-up of the new plant.」
The company continues to report increased production capacity and stable production following the start-up of the new plant. - FY2017-Q1AdvancedAnnual report
「The contract manufacturing of functional chemicals, pharmaceutical intermediates and other products continued stable production, mainly of functional materials and agrochemical intermediates, following the increase in production capacity from the start-up of the new plant.」
The new plant added in the previous fiscal year began operations, enabling stable production based on increased production capacity. - FY2016First statedAnnual report
「Yanai Chemical Industry Co., Ltd. is expanding its Yanai Plant by adding a new plant, increasing equipment capacity, achieving record-high net sales for 10 consecutive periods, and expanding the scale of its business.」
The company reported the addition of a new plant, capacity expansion, and record-high net sales for 10 consecutive periods.